Floris M Wachters

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy

Floris M Wachters, Liza S. M. Wong, Wim Timens et al. · Lung Cancer · 2005 · 88 citations

Medicine, Pathology, Cancer Biology +5

Selective targeting of homologous DNA recombination repair by gemcitabine

Floris M Wachters, John W.G. van Putten, Jan Gerard Maring et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 81 citations

Genome Instability, Selective Targeting, Molecular Biology +3

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

Floris M Wachters, J.W.G. van Putten, Henk Kramer et al. · British Journal of Cancer · 2003 · 61 citations · Full text

First-line Gemcitabine, Progression-free Survival, Oncology +12

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

Floris M Wachters, Harry J.M. Groen, Jan Gerard Maring et al. · British Journal of Cancer · 2004 · 50 citations · Full text

Determination of Epirubicin and Its Metabolite Epirubicinol in Saliva and Plasma by HPLC

Wilma I. W. Dodde, Jan Gerard Maring, G. Hendriks et al. · Therapeutic Drug Monitoring · 2003 · 33 citations